Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:FCHS NASDAQ:IVF OTCMKTS:WCUI OTCMKTS:ZICX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFCHSFirst Choice Healthcare Solutions$0.01+4.7%$0.01$0.00▼$0.01$297K0.8849,910 shs115,031 shsIVFINVO Fertility$2.50-1.1%$3.74$2.21▼$51.12$5.40M2.04381,055 shs198,021 shsWCUIWellness Center Usa$0.00$0.00▼$0.00N/A4.8965,499 shsN/AZICXZicix$0.00$0.00$0.00▼$0.00$550K1.7854,443 shsN/AThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFCHSFirst Choice Healthcare Solutions0.00%+53.85%0.00%+45.86%+68.63%IVFINVO Fertility0.00%-63.91%-77.05%+83,999,900.00%+83,999,900.00%WCUIWellness Center Usa0.00%0.00%-81.82%0.00%-87.50%ZICXZicix0.00%0.00%0.00%-14.29%+20.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFCHSFirst Choice Healthcare SolutionsN/AN/AN/AN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFCHSFirst Choice Healthcare Solutions 0.00N/AN/AN/AIVFINVO Fertility 0.00N/AN/AN/AWCUIWellness Center Usa 0.00N/AN/AN/AZICXZicix 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFCHSFirst Choice Healthcare Solutions$30K9.89N/AN/A($0.99) per share-0.01IVFINVO Fertility$6.53M0.83N/AN/A($29.86) per share-0.08WCUIWellness Center Usa$660K0.00N/AN/AN/ANaNZICXZicixN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFCHSFirst Choice Healthcare Solutions-$3.85M-$0.13N/A∞N/AN/AN/A-96.09%N/AIVFINVO Fertility-$9.10M-$34.06N/A∞N/A-377.73%N/A-88.18%N/AWCUIWellness Center Usa-$750KN/A0.00N/AN/AN/AN/AN/AN/AZICXZicixN/AN/A0.00∞N/AN/AN/AN/AN/ALatest ZICX, IVF, FCHS, and WCUI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025IVFINVO FertilityN/A-$37.59N/A-$12.53N/A$1.64 million5/15/2025Q1 2025FCHSFirst Choice Healthcare SolutionsN/A-$0.04N/A-$0.04N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFCHSFirst Choice Healthcare SolutionsN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/AWCUIWellness Center UsaN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFCHSFirst Choice Healthcare SolutionsN/AN/AN/AIVFINVO FertilityN/A0.080.07WCUIWellness Center UsaN/AN/AN/AZICXZicixN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFCHSFirst Choice Healthcare SolutionsN/AIVFINVO Fertility12.02%WCUIWellness Center Usa0.01%ZICXZicixN/AInsider OwnershipCompanyInsider OwnershipFCHSFirst Choice Healthcare Solutions30.81%IVFINVO Fertility0.57%WCUIWellness Center Usa15.70%ZICXZicixN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFCHSFirst Choice Healthcare Solutions20732.96 million22.80 millionNot OptionableIVFINVO Fertility102.16 million2.15 millionN/AWCUIWellness Center Usa8143.19 million120.71 millionNot OptionableZICXZicix2916.02 millionN/ANot OptionableZICX, IVF, FCHS, and WCUI HeadlinesRecent News About These CompaniesWhat to buy and skip during Amazon’s Prime Big Deal Days, according to expertsOctober 8, 2023 | nbcnews.comBest art supplies stores to shop online in the UKSeptember 22, 2023 | standard.co.ukSZicix Corporation (ZICX) Stock Historical Prices & Data - Yahoo FinanceSeptember 8, 2023 | finance.yahoo.com10 best die cutting machines for craft aficionadosAugust 31, 2023 | msn.comZICIX+CTIP-FII RECEIVES NOTICE TO PROCEED FROM PROJECT OWNER TO START THE $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEYMarch 6, 2023 | finance.yahoo.comZICIX AND ASIA BASED CONSTRUCTION GROUP AGREES TO FORM A CONSTRUCTION MANAGEMENT COMPANYNovember 28, 2022 | finance.yahoo.comZICIX + CTIP-FII RECEIVES ORDER FROM CITY OF KAKATA, LIBERIA TO BUY PASSENGER BUSESOctober 17, 2022 | finance.yahoo.comZICIX+CTIP-FII UPDATES STOCKHOLDERS ON PROJECTS ON-GOINGSeptember 6, 2022 | finance.yahoo.comZICIX owned CTIP-FII Receives Award from Liberia...August 24, 2022 | benzinga.comZICIX owned CTIP-FII Receives Award from Liberia's Ministry of Public Works for Road ProjectAugust 22, 2022 | tmcnet.comZICIX owned CTIP-FII Receives Award from Liberia’s Ministry of Public Works for Road ProjectAugust 22, 2022 | finance.yahoo.comZICIX Receives Health Ministry's Support for Hospital Project in SenegalAugust 13, 2022 | stockhouse.comZICIX OPERATING COMPANY SIGNS DEVELOPMENT CONTRACT TO BUILD HOSPITALSAugust 12, 2022 | finance.yahoo.comZICIX Finalizes Acquisition of CTIP-FIIAugust 12, 2022 | finance.yahoo.comZICIX AND CTIP-FII JOINS DEVELOPMENT OF P2A HOSPITAL PROJECT IN SENEGALAugust 12, 2022 | finance.yahoo.comZICIX Corporation to Develop P2A Hospital Project in SenegalAugust 12, 2022 | finance.yahoo.comZICIX Receives Health Ministry’s Support for Hospital Project in SenegalAugust 12, 2022 | finance.yahoo.comMedia Sentiment Over TimeZICX, IVF, FCHS, and WCUI Company DescriptionsFirst Choice Healthcare Solutions OTCMKTS:FCHS$0.0090 +0.00 (+4.65%) As of 10:10 AM EasternFirst Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.INVO Fertility NASDAQ:IVF$2.50 -0.03 (-1.12%) As of 11:28 AM EasternNAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).Wellness Center Usa OTCMKTS:WCUIWellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.Zicix OTCMKTS:ZICX$0.0006 0.00 (0.00%) As of 07/18/2025Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
